From Our Partners
Saturday, June 25, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Funding News

USAMRIID BSL4 Laboratory Coatings Assessment

by Global Biodefense Staff
June 18, 2014
Ebola Virus Research BSL 4 USAMRIID

The US Army has announced intentions to award a contract to Exponent, Inc. for testing and assessment of the special biosafety coating systems at the U.S. Army Medical Research Institute of Infectious Disease (USAMRIID) Replacement construction project.

The contract requires specific engineering tests on the existing USAMRIID Biosafety Level 4 (BSL4) coating products, including flammability testing, review of the current design, and conduct of a risk and hazard analysis.

The tests will help to determine if the existing wall coatings should be used in the completed facility, or removed and replaced with another system. The duration of the contract services is 120 days.

USAMRIID is the U.S Army’s main institution and facility for defensive research into countermeasures against biological warfare. It is located on Fort Detrick, Maryland and is a subordinate lab of the U. S. Army Medical Research and Materiel Command (USAMRMC), headquartered on the same installation. USAMRIID is the only U.S. Department of Defense (DoD) laboratory equipped to study highly hazardous viruses at BSL4.

The project is the largest, most complex biocontainment facility constructed and significantly decompresses and increases USAMRIID’s biomedical laboratory and vivarium research capabilities. This facility, when complete, will facilitate USAMRIID’s mission: to conduct basic and applied medical research resulting in vaccines, therapeutics, and diagnostic tools to protect military service members and the American public.

“The proposed contractor, Exponent, Inc. is a world-renowned engineering and scientific consultant. It is very familiar with all the type of coatings associated with the USAMRIID laboratories,” states the announcement. “Their knowledge of the prescribed coatings and their ability to rapidly respond makes them the most appropriate contractor for this action.”

Source: FBO.gov

From Our Partners
Tags: AwardsBiosafetyUSAMRIID

Related Posts

Biodefense Industry News
Industry News

Tonix Pharmaceuticals Opens Advanced Development Center for Vaccine Programs

June 20, 2022
Novavax Missed Its Global Moonshot but Is Angling to Win Over mRNA Defectors
Industry News

Novavax Missed Its Global Moonshot but Is Angling to Win Over mRNA Defectors

May 26, 2022
NIH to Further Invest in Point-of-Care Technologies Research Network
Biodetection

NIH to Further Invest in Point-of-Care Technologies Research Network

May 10, 2022
Supplemental Funding for Research at NIAID Regional Biocontainment Laboratories
Biosecurity

Supplemental Funding for Research at NIAID Regional Biocontainment Laboratories

May 5, 2022
Load More

Latest News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Influenza Research

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC